Search Results - "Christoffer El‐Galaly, Tarec"
-
1
Pre‐treatment total metabolic tumour volumes in lymphoma: Does quantity matter?
Published in British journal of haematology (01-04-2022)“…Summary Positron emission tomography/computed tomography (PET/CT) is used for the staging of lymphomas. Clinical information, such as Ann Arbor stage and…”
Get full text
Journal Article -
2
Bone health and glucocorticoid‐containing lymphoma therapy — a review of risk factors and preventative measures
Published in British journal of haematology (01-08-2022)“…With survival outcomes ever improving for patients with a wide range of lymphoma histologies, the focus on reducing long‐term complications of therapy has…”
Get full text
Journal Article -
3
Late relapses in Hodgkin lymphoma – should we search for the needle in the haystack?
Published in British journal of haematology (01-07-2022)“…Hodgkin lymphoma is among the most curable cancers. For patients in remission for 24 months, residual lifetime becomes close to that of the background…”
Get full text
Journal Article -
4
Mantle Cell Lymphoma of Mucosa‐Associated Lymphoid Tissue: A European Mantle Cell Lymphoma Network Study
Published in HemaSphere (01-02-2020)“…Supplemental Digital Content is available in the text While classical nodal mantle cell lymphoma (cMCL) is often associated with involvement of multiple…”
Get full text
Journal Article -
5
Routine imaging for disease surveillance in follicular lymphoma—To comfort the patients or their doctors?
Published in Cancer (15-09-2021)“…The effectiveness and outcomes of routine imaging for disease surveillance in lymphomas have been questioned. In patients with follicular lymphoma, no clinical…”
Get full text
Journal Article -
6
Mantle cell lymphoma — where precision medicine based on response‐adapted treatment strategies could show its full worth
Published in British journal of haematology (01-05-2020)Get full text
Journal Article -
7
Detecting deviations from the efficacy and safety results of single‐arm trials using real‐world data: The case of a CAR‐T cell therapy in B‐cell lymphoma
Published in Pharmacoepidemiology and drug safety (01-04-2021)“…Purpose Personalized therapies are leading to an increasing number of marketing authorizations based on single‐arm trials, which increases the demand for…”
Get full text
Journal Article -
8
Long‐term cause‐specific mortality in adolescent and young adult Hodgkin lymphoma patients treated with contemporary regimens—A nationwide Danish cohort study
Published in British journal of haematology (01-10-2024)“…Summary The documented treatment‐induced excess mortality in Hodgkin lymphoma (HL) has spurred important treatment changes over recent decades. This study…”
Get full text
Journal Article -
9
Primary gastric diffuse large B‐cell lymphoma: A multicentre retrospective study
Published in British journal of haematology (01-08-2024)“…Summary Primary gastric diffuse large B‐cell lymphoma (PG‐DLBCL) accounts for the majority of extra‐nodal DLBCL. Even so, literature is lacking on early,…”
Get full text
Journal Article -
10
Effects of chemotherapy dose reductions in overweight patients with acute myeloid leukaemia: A Danish nationwide cohort study
Published in British journal of haematology (01-11-2022)“…Summary Overweight patients with cancer are frequently reduced in chemotherapy dose due to toxicity concerns, although previous studies have indicated that…”
Get full text
Journal Article -
11
Real-world outcomes following third or subsequent lines of therapy: A Danish population-based study on 189 patients with relapsed/refractory large B-cell lymphomas
Published in British journal of haematology (01-03-2024)“…Outcome data of patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) beyond the second line are scarce outside of clinical trials…”
Get full text
Journal Article -
12
Temporal changes in survival among adult patients with acute myeloid leukaemia in the period 2000–2016: a Danish population‐based study
Published in British journal of haematology (01-05-2021)“…Summary In the present study, we quantify the progress in overall survival (OS) during the period 2000–2016 among Danish patients with acute myeloid leukaemia…”
Get full text
Journal Article -
13
miR-155 as a Biomarker in B-Cell Malignancies
Published in BioMed research international (01-01-2016)“…MicroRNAs have the potential to be useful biomarkers in the development of individualized treatment since they are easy to detect, are relatively stable during…”
Get full text
Journal Article -
14
Outcome of limited‐stage peripheral T‐Cell lymphoma after CHOP(−like) therapy: A population based study of 239 patients from the Nordic lymphoma epidemiology group
Published in American journal of hematology (01-03-2023)“…Peripheral T‐Cell Lymphomas (PTCLs) are rare, aggressive lymphomas with poor outcomes, but limited‐stage disease is infrequent and not well‐described. This…”
Get full text
Journal Article -
15
Effectiveness of R-CHOP versus R-CHOEP for treatment of young patients with high-risk diffuse large B-cell lymphoma: A Danish observational population-based study
Published in European journal of haematology (01-11-2024)“…Etoposide to standard R-CHOP is used for high-risk diffuse large B-cell lymphoma (DLBCL) in some countries. Due to the lack of randomized trials, a real-world…”
Get full text
Journal Article -
16
Routine Bone Marrow Biopsy Has Little or No Therapeutic Consequence for Positron Emission Tomography/Computed Tomography–Staged Treatment-Naive Patients With Hodgkin Lymphoma
Published in Journal of clinical oncology (20-12-2012)“…To investigate whether bone marrow biopsy (BMB) adds useful information to [(18)F]fluorodeoxyglucose (FDG) positron emission tomography/computed tomography…”
Get full text
Journal Article -
17
-
18
Revisiting beta‐2 microglobulin as a prognostic marker in diffuse large B‐cell lymphoma
Published in Cancer medicine (Malden, MA) (01-06-2024)“…Background Several clinical prognostic models for diffuse large B‐cell lymphoma (DLBCL) have been proposed, including the most commonly used International…”
Get full text
Journal Article -
19
A prognostic model integrating PET‐derived metrics and image texture analyses with clinical risk factors from GOYA
Published in EJHaem (01-05-2022)“…Image texture analysis (radiomics) uses radiographic images to quantify characteristics that may identify tumour heterogeneity and associated patient outcomes…”
Get full text
Journal Article -
20
A Lack of Diversity, Equity, and Inclusion in Clinical Research Has Direct Impact on Patient Care
Published in HemaSphere (01-03-2023)Get full text
Journal Article